The dual SGLT1/2 inhibitor sotagliflozin (Inpefa ... as it has not been observed in trials of selective SGLT2 inhibitors." "These results demonstrate a new mechanism of action -- combined blockade ...

Preoperative use of SGLT2 inhibitors among patients with ... (Jardiance), ertugliflozin (Steglatro), and the dual SGLT1/2 ...

Sotagliflozin, a dual SGLT1/2 inhibitor ... Sotagliflozin is a dual sodium-glucose co-transporter (SGLT)-1 and SGLT2 inhibitor that acts in the gastrointestinal tract and kidneys, respectively.

SGLT2 inhibitors are medications designed to help manage blood sugar in people living with type 2 diabetes. Learn more about the different types, as well as the benefits and side effects.

A major new study finds that certain diabetes medications, including GLP-1 and SGLT2 inhibitors, may be linked to a reduced ...

Cardiovascular effectiveness was observed, largely independent of age, in a cohort of older patients with type 2 diabetes.

The two questions addressed in this “pragmatic” trial — whether adjunctive SGLT2 inhibitors are beneficial after TAVI and whether SGLT2 inhibitors are safe in older patients — were ...

SGLT2 inhibitors significantly improve hemoglobin and hematocrit levels in CKD patients, enhancing anemia management. The KDIGO 2024 guideline endorses SGLT2 inhibitors for CKD patients ...

Preoperative SGLT2 inhibitor use was not associated with an increased risk for postoperative diabetic ketoacidosis among patients with type 2 diabetes. Use of sodium-glucose cotransporter 2 ...